e-learning
resources
European Respiratory Review
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Drug-induced pulmonary arterial hypertension: a recent outbreak},
David Montani, Andrei Seferian, Laurent Savale, Gérald Simonneau, Marc Humbert
Source:
Eur Respir Rev 2013; 22: 244-250
Journal Issue:
September 2013 - 22 (129)
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
David Montani, Andrei Seferian, Laurent Savale, Gérald Simonneau, Marc Humbert. Drug-induced pulmonary arterial hypertension: a recent outbreak},. Eur Respir Rev 2013; 22: 244-250
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Survival in pulmonary hypertension in Spain: insights from the Spanish registry},
Source: Eur Respir J 2012; 40: 596-603
Year: 2012
Chronic post-embolic pulmonary hypertension: a new target for medical therapies?},
Source: Eur Respir Rev 2013; 22: 258-264
Year: 2013
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era},
Source: Eur Respir J 2012; 40: 881-885
Year: 2012
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020
Year: 2020
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010
Pulmonary hypertension in chronic interstitial lung diseases},
Source: Eur Respir Rev 2013; 22: 292-301
Year: 2013
Pulmonary arterial hypertension: a comparison between children and adults
Source: Eur Respir J 2011; 37: 665-677
Year: 2011
Pulmonary hypertension and pulmonary vascular disease: course report
Source: Breathe, 14 (1) e4; 10.1183/20734735.019917
Year: 2018
Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003
An epidemiological study of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: 104-109
Year: 2007
Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPH},
Source: Eur Respir J 2012; 40: 612-617
Year: 2012
Predicting survival in pulmonary arterial hypertension in the UK},
Source: Eur Respir J 2012; 40: 604-611
Year: 2012
Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients},
Source: Eur Respir J 2012; 40: 630-640
Year: 2012
A USA-based registry for pulmonary arterial hypertension: 1982 2006
Source: Eur Respir J 2007; 30: 1103-1110
Year: 2007
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases
Source: Eur Respir J 2008; 31: 343-348
Year: 2008
ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021
Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
Source: Eur Respir J 2010; 36: 792-799
Year: 2010
Pulmonary arterial hypertension case
Source: International Congress 2016 – ERS-ALAT-SBPT-SEPAR-SPP joint session: Spanish and Portuguese Session II
Year: 2016
Pulmonary arterial hypertension: an autoimmune disease?
Source: Eur Respir J 2005; 26: 986-988
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept